Clonal hematopoiesis in myeloid malignancies and solid tumors

Area of Science:

• Hematology
• Oncology
• Cancer Biology

Background:

• Clonal hematopoiesis (CH) arises from the clonal expansion of hematopoietic stem cells.
• CH is associated with an elevated risk of hematologic malignancies and increased mortality in patients with solid tumors.

Purpose of the Study:

• To elucidate the mechanisms driving CH in both blood cancers and solid tumors.
• To review strategies for intercepting CH and their potential impact on solid tumor therapies, including immunotherapy.

Main Methods:

• Literature review and synthesis of current research on CH mechanisms.
• Analysis of proposed CH interception strategies and their implications for cancer treatment.

Main Results:

• Identified shared and distinct mechanisms driving CH in hematologic and solid tumors.
• Evaluated the potential of CH-targeting interventions in the context of solid tumor therapy.

Conclusions:

• Understanding the interplay between CH and cancer is critical for improving patient outcomes.
• Interception strategies for CH may offer novel therapeutic avenues for solid tumor patients, particularly those involving immunotherapy.